시장보고서
상품코드
1149861

비소세포폐암 시장 : 유형별, 치료법별(화학요법, 표적치료(베바시주맙, 네시투뮤맵, 라무시루맙), 면역치료), 최종사용자별, 지역별 - 규모, 점유율, 전망, 기회 분석(2022-2030년)

Non-Small Cell Lung Cancer Market, by Type, by Treatment (Chemotherapy, Targeted Therapy (Bevacizumab, Necitumumab, and Ramucirumab, Immunotherapy, by End user, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

발행일: | 리서치사: Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

폐암의 증상은 폐렴 및 폐의 허탈 등 기타 질병의 증상으로 생각되므로 초기에는 눈에 띄지 않습니다. 폐암의 증상으로는 가슴 통증, 호흡시 거친 소리, 천명, 체중 감소, 계속되는 기침, 쉰 목소리 및 변성, 호흡 곤란, 기관지염 및 폐렴 등의 폐 질병 등이 있습니다.

목차

제1장 조사 목적과 전제조건

  • 조사 목적
  • 전제조건
  • 약어 설명

제2장 시장의 전망

  • 리포트 내용
    • 시장의 정의와 범위
  • 주요 요약
    • 시장 스냅숏 : 유형별
    • 시장 스냅숏 : 치료법별
    • 시장 스냅숏 : 최종사용자별
    • 시장 스냅숏 : 지역별
  • COM(Coherent Opportunity Map)

제3장 시장 역학, 규제, 동향 분석

  • 시장 역학
    • 촉진요인
    • 억제요인
    • 시장 기회
  • 영향 분석
  • 시장 동향
  • 최근 동향
  • 인수와 파트너십 시나리오
  • 기술 개요
  • 법규제 시나리오
  • 파이프라인 분석
  • PEST 분석

제4장 세계의 비소세포폐암 치료 시장 - COVID-19영향 분석

  • 전체에 대한 영향
  • 수급에 대한 영향
  • 시장에 대한 COVID-19의 영향

제5장 세계의 비소세포폐암 치료 시장(유형별), 2017-2030년

  • 선암(Adenocarcinoma)
  • 편평상피암(Squamous Cell Carcinoma)
  • 대세포암
  • 대세포 신경내분비종양

제6장 세계의 비소세포폐암 치료 시장(치료법별) : 2017-2030년

  • 화학요법
  • 표적 치료
  • 베바시주맙(Avastin)
  • 네시투뮤맵(Portrazza)
  • 라무시루맙(Cyramza)
  • 면역치료
  • 니볼루맙(Opdivo)
  • 아테졸리주맙(Tecentriq)
  • 기타

제7장 세계의 비소세포폐암 치료 시장 : 최종사용자별, 2017-2030년

  • 병원
  • 재택의료
  • 전문 클리닉
  • 기타

제8장 세계의 비소세포폐암 치료 시장 : 지역별, 2017-2030년

  • 북미
  • 미국
  • 캐나다
  • 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
  • 기타 라틴아메리카 지역
  • 유럽
  • 영국
  • 독일
  • 이탈리아
  • 프랑스
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 중국
  • 인도
  • 일본
  • ASEAN
  • 호주
  • 한국
  • 기타 아시아태평양
  • 중동 지역
  • GCC
  • 이스라엘
  • 기타 중동 지역
  • 아프리카
  • 북아프리카
  • 중앙아프리카
  • 남아프리카

제9장 경쟁 구도

  • Pfizer Inc.
  • AstraZeneca plc
  • F. Hoffmann-La Roche Ltd.
  • Eli Lilly and Company
  • Boehringer Ingelheim GMBH
  • Novartis AG
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.

제10장 섹션

  • 조사 방법
  • Coherent Market Insights 소개
KSA 22.11.21

Lung cancer symptoms are not noticeable in its early stage as these symptoms are considered for other type of illness such as pneumonia or collapsed lung. Some symptoms of lung cancer include chest pain, harsh/raspy sound while breathing, wheezing, weight loss, continuous cough, hoarseness or voice changes, shortness of breath, lung problems such as bronchitis or pneumonia, and others. Moreover, if it spreads through the bloodstream or the lymphatics into other parts of the body then it exhibits symptoms such as bone pain, weakness in arm or leg, yellow skin, yellow eyes, headache, and seizures.

Some diagnostic tests are performed by doctors to detect lung cancer, which include diagnostic imaging tests such as X-ray, magnetic resonance imaging (MRI), ultrasound, computed tomography scan (CT scan), and also by diagnosing mucous, which the patient can cough up to check the presence of cancer cells, which is called as sputum cytology. By taking the cells of lungs from abnormal growth area of the lung or from the fluid of lungs through the procedure called as fine needle aspiration biopsy, bronchoscopy, and mediastinoscopy, lung cancer can be diagnosed.

Market Dynamics

Increasing consumption of tobacco and active engagement in passive smoking are two major factors responsible for non-small cell lung cancer, which are expected to drive market growth over the forecast period. For instance, according to data published in March 2022, on The Centers for Disease Control and Prevention (CDC), stated that nearly 40 million U.S. adults smoke cigarettes, and an estimated 2.55 million middle and high school students use at least one tobacco product, including e-cigarettes every year.

Key features of the study:

  • This report provides in-depth analysis of the global non-small cell lung cancer treatment market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global non-small cell lung cancer market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Pfizer Inc., AstraZeneca plc, F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Boehringer Ingelheim GMBH, Novartis AG, Bristol-Myers Squibb Company, and Merck & Co., Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global non-small cell lung cancer treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global non-small cell lung cancer market

Detailed Segmentation:

  • Global Non-small Cell Lung Cancer Treatment Market, By Type:
    • Adenocarcinoma
    • Squamous Cell Carcinoma
    • Large Cell Carcinoma
    • Large Cell Neuroendocrine Tumors
  • Global Non-small Cell Lung Cancer Treatment Market, By Treatment:
    • Chemotherapy
    • Targeted Therapy
      • Bevacizumab (Avastin)
      • Necitumumab (Portrazza)
      • Ramucirumab (Cyramza)
    • Immunotherapy
      • Nivolumab (Opdivo)
      • Atezolizumab (Tecentriq)
    • Others
  • Global Non-small Cell Lung Cancer Treatment Market, By End User:
    • Hospitals
    • Homecare
    • Specialty Clinics
    • Others
  • Global Non-small Cell Lung Cancer Treatment Market, By Region:
    • North America
      • By Country
    • U.S.
    • Canada
    • Latin America
      • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
      • By Country
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Country
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
      • By Country
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Region/Country
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Pfizer Inc.
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • AstraZeneca plc
    • Hoffmann-La Roche Ltd.
    • Eli Lilly and Company,
    • Boehringer Ingelheim GMBH
    • Novartis AG
    • Bristol-Myers Squibb Company
    • Merck & Co., Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Treatment
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Recent Developments
  • Acquisitions and Partnerships Scenario
  • Technology Overview
  • Regulatory Scenario
  • Pipeline Analysis
  • PEST Analysis

4. Global Non-small Cell Lung Cancer Treatment Market- COVID-19 Impact Analysis

  • Overall Impact
  • Impact on Supply and Demand
  • COVID-19 Impact on the market

5. Global Non-small Cell Lung Cancer Treatment Market, By Type, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Adenocarcinoma
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Squamous Cell Carcinoma
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Large Cell Carcinoma
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Large Cell Neuroendocrine Tumors
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Non-small Cell Lung Cancer Treatment Market, By Treatment, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Chemotherapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Targeted Therapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Bevacizumab (Avastin)
  • Necitumumab (Portrazza)
  • Ramucirumab (Cyramza)
  • Immunotherapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Nivolumab (Opdivo)
  • Atezolizumab (Tecentriq)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Non-small Cell Lung Cancer Treatment Market, By End User, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Hospitals
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Homecare
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Specialty Clinics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Non-small Cell Lung Cancer Treatment Market, By Region, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • AstraZeneca plc
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • F. Hoffmann-La Roche Ltd.
    • Company Highlights
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Eli Lilly and Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boehringer Ingelheim GMBH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Novartis AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bristol-Myers Squibb Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Merck & Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

10. Section

  • Research Methodology
  • About Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제